Novo Nordisk

Novo Nordisk hit by insulin drug doubts, downgrade
Marketwatch
Tue, 03/19/13 - 10:53 am
insulin
Novo Nordisk
Tresiba
Novo Nordisk Says Trial Shows Victoza Helps Patients Lose Weight
Bloomberg
Mon, 03/18/13 - 11:22 am
Novo Nordisk
Victoza
obesity
diabetes
4 Stocks Pushing The Health Care Sector Higher
The Street
Sat, 03/16/13 - 10:49 am
Novo Nordisk
Sanofi
Novartis
Alexion
Longer Lasting Drugs Make For Longer Lasting Profits
Seeking Alpha
Fri, 03/15/13 - 10:54 am
AntriaBio
AstraZeneca
Novo Nordisk
Sanofi
Bristol-Myers Squibb
Diabetes Drugs Are Being Evaluated for Pancreatic Risk
Bloomberg
Thu, 03/14/13 - 11:15 am
pancreatic cancer
diabetes
Merck
Januvia
Bristol-Myers Squibb
Byetta
Novo Nordisk
Victoza
U.S. rejection of Novo drug seen temporary but costly
Yahoo/Reuters
Thu, 02/21/13 - 12:03 pm
Novo Nordisk
Tresiba
diabetes
Sanofi advances after FDA delays rival insulin product
The Fly on the Wall
Mon, 02/11/13 - 11:07 am
FDA
insulin
Novo Nordisk
Sanofi
Tresiba
Lantus
Novo Nordisk hit hard as U.S. rebuffs insulin drug
Yahoo/Reuters
Mon, 02/11/13 - 08:15 am
insulin
Novo Nordisk
diabetes
FDA
Tresiba
Alas, Hamlet! A Diabetes Drugmaker to Renew the Faith
Motley Fool
Tue, 02/5/13 - 10:49 am
diabetes
Novo Nordisk
Danish drug maker Novo Nordisk in $1 billion net profit on strong sales of insulins
Yahoo/AP
Thu, 01/31/13 - 10:40 am
Novo Nordisk
earnings
Novo Nordisk A/S Reaches New 52-Week High (NVO)
The Street
Wed, 01/30/13 - 06:12 pm
Novo Nordisk
52 week high
stock
Eli Lilly May Have The Best Chance At Keeping The Momentum Going
Seeking Alpha
Wed, 01/30/13 - 04:16 pm
Eli Lilly
Bristol-Myers Squibb
Novo Nordisk
Pfizer
Sanofi
Big Pharma Diabetes Face-Off
The Motley Fool
Sat, 01/19/13 - 11:07 am
Pharma
diabetes
Bristol-Myers Squibb
Astra Zeneca
Novo Nordisk
GlaxoSmithKline
Analysis: Drug industry bets on new blockbusters in 2013
Reuters
Tue, 01/15/13 - 11:37 am
Roche
GlaxoSmithKline
Eli Lilly
Biogen Idec
Gilead Sciences
Novo Nordisk
Japan gives initial OK to Novo's insulin combo, Ryzodeg
Fierce Pharma
Thu, 12/27/12 - 10:32 pm
Japan
Novo Nordisk
Ryzodeg
The Next Wave of Diabetes Dominance
Motley Fool
Wed, 12/12/12 - 08:11 am
diabetes
Bayer
Sanofi
Novo Nordisk
Abbott Labs
Bristol-Myers Squibb
This Top Big Pharma Stock Just Got an Upgrade
Motley Fool
Sat, 12/8/12 - 11:31 am
Novo Nordisk
Glaxo Doubts GLP-1s Would Be Cleared as Drugs for Obesity
Bloomberg
Tue, 12/4/12 - 11:55 am
GSK
GLP-1 agonist
obesity
diabetes
albiglutide
Victoza
Novo Nordisk
Novo Nordisk says new data show Victoza advantage
Reuters
Tue, 11/27/12 - 10:36 am
diabetes
Novo Nordisk
Victoza
Merck
Amylin
Novo Nordisk A/S: Catching The Increasing Diabetes Trend
Seeking Alpha
Tue, 11/20/12 - 11:27 am
diabetes
Novo Nordisk
Bristol-Myers Squibb
Eli Lilly
Sanofi

Pages